SKI Market

Indian Indices

Sensex

85,323.16 102.56
( 0.12%)

Global Indices

Nasdaq

48,085.52 -302.55
(-0.63%)

Dow Jones

6,867.73 -49.51
(-0.72%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kabra Drugs Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524322

INE323K01017

10.9633096

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

61.1

72.43

EPS(TTM)

Face Value()

Div & Yield %

0.5

Back

Kabra Drugs Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On 08 Th October 2025 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

Oct 08,2025

Outcome of Board Meeting held on 08 th October 2025 as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

85,323.16 102.56 ( 0.12%)

48,085.52 -302.55 (-0.63%)

6,867.73 -49.51 (-0.72%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)